Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party

Affiliations

• ¹ Hematology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France.
• ² Hematology, Centre Hospitalier Lyon-Sud, Pierre-Benite, France [email protected].
• ³ Histocompatibility, Etablissement Français du Sang, Lyon, France.
• ⁴ Biostatistics, University Tor Vergata, Rome, Italy.
• ⁵ EBMT Data Office, Leiden, the Netherlands.
• ⁶ CHU Lapeyronie, Montpellier, France.
• ⁷ CHU Bordeaux, France.
• ⁸ University Hospital of Freiburg, Germany.
• ⁹ Institut Paoli-Calmettes, Marseille, France.
• ¹⁰ Haga Hospital, The Hague, the Netherlands.
• ¹¹ VU University Medical Center, Amsterdam, the Netherlands.
• ¹² Leiden University Medical Center, the Netherlands.
• ¹³ University Medical Centre, Utrecht, the Netherlands.
• ¹⁴ Nottingham University, UK.
• ¹⁵ Manchester Royal Infirmary, UK.
• ¹⁶ University Hospital, Basel, Switzerland.
• ¹⁷ Hopital Michallon, Grenoble, France.
• ¹⁸ University Hospital Gasthuisberg, Leuven, Belgium.
• ¹⁹ CHU Nantes, France.
• ²⁰ Hopital La Miletrie, Poitiers, France.
• ²¹ HUCH Comprehensive Cancer Center, Helsinki, Finland.
• ²² CHRU, Angers, France.
• ²³ Nouvel Hopital Civil, Strasbourg, France.
• ²⁴ University Hospital of Liege, Belgium.
• ²⁵ Eurocord - Hopital St Louis, Paris, France.
• ²⁶ Hospital Saint-Antoine, Paris, France.
• ²⁷ University Hospital Eppendorf, Hamburg, Germany.